FDA issues bismacine-chromacine warning

Jul 24, 2006

The U.S. Food and Drug Administration is warning consumers and healthcare providers not to use a product called bismacine, also known as chromacine.

The FDA says it is investigating one report of a death and several reports of injury related to the administration of bismacine -- an injectable product that has been used to treat Lyme disease.

FDA officials said bismacine, which is not approved for anything, including Lyme disease, is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.

The product contains high amounts of bismuth, a heavy metal that is used in some medications to treat Helicobacter pylori, a bacteria that can cause stomach ulcers but that is not approved in any form for use by injection.

Copyright 2006 by United Press International

Explore further: Facial masculinity not always a telling factor in mate selection

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Note to young men: Fat doesn't pay

8 minutes ago

Men who are already obese as teenagers could grow up to earn up to 18 percent less than their peers of normal weight. So says Petter Lundborg of Lund University, Paul Nystedt of Jönköping University and ...

Study finds gallbladder surgery can wait

1 hour ago

Laparoscopic cholecystectomy, a minimally invasive procedure to remove the gallbladder, is one of the most common abdominal surgeries in the U.S. Yet medical centers around the country vary in their approaches to the procedure ...

US warns Ebola could infect 1.4 million by 2015

1 hour ago

The number of Ebola infections in Liberia and Sierra Leone could skyrocket to 1.4 million by January 2015, according to a worst-case scenario released by US health authorities Tuesday.

User comments : 0